Low-dose Radiation Therapy in the Management of COVID-19 Pneumonia (LOWRAD-Cov19). Final results of a prospective phase I

Low-dose Radiation Therapy in the Management of COVID-19 Pneumonia (LOWRAD-Cov19). Final results of a prospective phase I–II trial

Published:2022-06 Issue: Volume:171 Page:25-29
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Sanmamed Noelia,Alcantara Pino,Gómez Sara,Bustos Ana,Cerezo Elena,Gaztañaga Miren,Doval Anxela,Corona Juan,Rodriguez Gabriel,Cabello Noemi,Duffort Mercedes,Ortuño Francisco,de Castro Javier,López Amanda,Fuentes Manuel,Sanz Alvaro,Vazquez Manuel

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference30 articles.

1. https://bestpractice.bmj.com/topics/en-gb/3000201/epidemiology.

2. https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases.

3. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet,2020

4. Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry;Casas-Rojo;Rev Clin Española (English Edition),2020

5. A review of potential suggested drugs for coronavirus disease (COVID-19) treatment;Tarighi;Eur J Pharmacol,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Low-Dose Lung Radiotherapy for Severe COVID-19 Pneumonia a Therapeutic Alternative?;Cureus;2024-07-21

2. Low-Dose Radiation Therapy (LDRT) against Cancer and Inflammatory or Degenerative Diseases: Three Parallel Stories with a Common Molecular Mechanism Involving the Nucleoshuttling of the ATM Protein?;Cancers;2023-02-26

3. In Regard to Kolahdouzan et al.;International Journal of Radiation Oncology*Biology*Physics;2023-01

4. In Reply to Li et al.;International Journal of Radiation Oncology*Biology*Physics;2023-01

5. Letter regarding “The clinical efficacy of low-dose whole-lung irradiation in moderate-to-severe COVID-19 pneumonia: RTMX-20 trial”;Radiotherapy and Oncology;2023-01